Health-related quality of life in seven European countries throughout the course of the COVID-19 pandemic: evidence from the European COvid Survey (ECOS). 2023

Hans-Helmut König, and Sebastian Neumann-Böhme, and Iryna Sabat, and Jonas Schreyögg, and Aleksandra Torbica, and Job van Exel, and Pedro Pita Barros, and Tom Stargardt, and André Hajek
Department of Health Economics and Health Services Research, University Medical Center Hamburg-Eppendorf, Hamburg Center for Health Economics, Martinistr. 52, 20246, Hamburg, Germany. h.koenig@uke.uni-hamburg.de.

OBJECTIVE To investigate health-related quality of life (HRQoL) over the course of the COVID-19 pandemic in seven European countries and its association with selected sociodemographic as well as COVID-19-related variables. METHODS We used longitudinal data from nine quarterly waves collected between April 2020 and January 2022 (sample size per wave ranging from N = 7025 to 7300) of the European COvid Survey (ECOS), a representative survey of adults in Germany, United Kingdom, Denmark, Netherlands, France, Portugal and Italy. HRQoL was measured using the EQ-5D-5L. The association of self-reported COVID-19 infection, perceived health risk from COVID-19, selected sociodemographic variables and the COVID-19 stringency index with HRQoL was analyzed by logistic and linear fixed effects regressions. RESULTS On average across all nine waves, the proportion of respondents reporting any problems in at least one of the EQ-5D dimensions ranged between 63.8% (Netherlands) and 71.0% (Denmark). Anxiety/depression was the most frequently affected EQ-5D dimension in four countries (Portugal: 52.0%; United Kingdom: 50.2%; Italy: 49.2%; France: 49.0%), whereas pain/discomfort ranked first in three countries (Denmark: 58.3%; Germany: 55.8%; Netherlands: 49.0%). On average across all nine waves, the EQ-VAS score ranged from 70.1 in the United Kingdom to 78.4 in Portugal. Moreover, the EQ-5D-5L index ranged from .82 in Denmark to .94 in France. The occurrence of COVID-19 infection, changes in the perceived risk to one's own health from COVID-19, the occurrence of income difficulties and an increase in the COVID-19 stringency index were associated with increased likelihood of problems in EQ-5D dimensions, reduced EQ-VAS score and reduced EQ-5D-5L index. CONCLUSIONS Across seven European countries, we found large proportions of respondents reporting problems in HRQoL dimensions throughout the pandemic, especially for anxiety/depression. Various sociodemographic and COVID-19-related variables were associated with HRQoL in longitudinal analysis.

UI MeSH Term Description Entries
D011788 Quality of Life A generic concept reflecting concern with the modification and enhancement of life attributes, e.g., physical, political, moral, social environment as well as health and disease. HRQOL,Health-Related Quality Of Life,Life Quality,Health Related Quality Of Life
D011795 Surveys and Questionnaires Collections of data obtained from voluntary subjects. The information usually takes the form of answers to questions, or suggestions. Community Survey,Nonrespondent,Questionnaire,Questionnaires,Respondent,Survey,Survey Method,Survey Methods,Surveys,Baseline Survey,Community Surveys,Methodology, Survey,Nonrespondents,Questionnaire Design,Randomized Response Technique,Repeated Rounds of Survey,Respondents,Survey Methodology,Baseline Surveys,Design, Questionnaire,Designs, Questionnaire,Methods, Survey,Questionnaire Designs,Questionnaires and Surveys,Randomized Response Techniques,Response Technique, Randomized,Response Techniques, Randomized,Survey, Baseline,Survey, Community,Surveys, Baseline,Surveys, Community,Techniques, Randomized Response
D006304 Health Status The level of health of the individual, group, or population as subjectively assessed by the individual or by more objective measures. General Health,General Health Level,General Health Status,Level of Health,Overall Health,Overall Health Status,General Health Levels,Health Level,Health Level, General,Health Levels,Health Status, General,Health Status, Overall,Health, General,Health, Overall,Level, General Health,Levels, General Health,Status, General Health,Status, Health,Status, Overall Health
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D058873 Pandemics Epidemics of infectious disease that have spread to many countries, often more than one continent, and usually affecting a large number of people. Pandemic

Related Publications

Hans-Helmut König, and Sebastian Neumann-Böhme, and Iryna Sabat, and Jonas Schreyögg, and Aleksandra Torbica, and Job van Exel, and Pedro Pita Barros, and Tom Stargardt, and André Hajek
January 2002, Homeopathy : the journal of the Faculty of Homeopathy,
Hans-Helmut König, and Sebastian Neumann-Böhme, and Iryna Sabat, and Jonas Schreyögg, and Aleksandra Torbica, and Job van Exel, and Pedro Pita Barros, and Tom Stargardt, and André Hajek
August 2023, Health and quality of life outcomes,
Hans-Helmut König, and Sebastian Neumann-Böhme, and Iryna Sabat, and Jonas Schreyögg, and Aleksandra Torbica, and Job van Exel, and Pedro Pita Barros, and Tom Stargardt, and André Hajek
July 2024, Archives of gerontology and geriatrics,
Hans-Helmut König, and Sebastian Neumann-Böhme, and Iryna Sabat, and Jonas Schreyögg, and Aleksandra Torbica, and Job van Exel, and Pedro Pita Barros, and Tom Stargardt, and André Hajek
January 2020, PloS one,
Hans-Helmut König, and Sebastian Neumann-Böhme, and Iryna Sabat, and Jonas Schreyögg, and Aleksandra Torbica, and Job van Exel, and Pedro Pita Barros, and Tom Stargardt, and André Hajek
January 2022, Frontiers in public health,
Hans-Helmut König, and Sebastian Neumann-Böhme, and Iryna Sabat, and Jonas Schreyögg, and Aleksandra Torbica, and Job van Exel, and Pedro Pita Barros, and Tom Stargardt, and André Hajek
October 2023, Health policy (Amsterdam, Netherlands),
Hans-Helmut König, and Sebastian Neumann-Böhme, and Iryna Sabat, and Jonas Schreyögg, and Aleksandra Torbica, and Job van Exel, and Pedro Pita Barros, and Tom Stargardt, and André Hajek
July 2014, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology,
Hans-Helmut König, and Sebastian Neumann-Böhme, and Iryna Sabat, and Jonas Schreyögg, and Aleksandra Torbica, and Job van Exel, and Pedro Pita Barros, and Tom Stargardt, and André Hajek
January 2022, PloS one,
Hans-Helmut König, and Sebastian Neumann-Böhme, and Iryna Sabat, and Jonas Schreyögg, and Aleksandra Torbica, and Job van Exel, and Pedro Pita Barros, and Tom Stargardt, and André Hajek
September 2022, Health and quality of life outcomes,
Hans-Helmut König, and Sebastian Neumann-Böhme, and Iryna Sabat, and Jonas Schreyögg, and Aleksandra Torbica, and Job van Exel, and Pedro Pita Barros, and Tom Stargardt, and André Hajek
October 2022, Journal of patient-reported outcomes,
Copied contents to your clipboard!